Rein Therapeutics, Inc. (RNTX)
CIK 1420565 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 85.5M shares as of May 13, 2026 (10-Q). Share count fell from 90.8M to 4.5M between Oct 28, 2022 and Mar 16, 2023, a pattern consistent with a reverse split (roughly 1-for-20); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.
Cash runway
~3 months of cash left
critical · burning $4.8M / quarter
Full breakdown: cash runway tool · source filing →
Warrants
| Tranche | Warrants | Exercise price | Term | Notes |
|---|---|---|---|---|
| Two Thousand Twenty Three Warrants | not tagged | $4.89 | — | — |
| Two Thousand Twenty Four Warrants | not tagged | $4.68 | — | — |
| Exchange Pre-Funded Warrants | not tagged | $0.001 | — | — |
| Bios Pre-Funded Warrants | not tagged | $0.001 | — | — |
| Pre Funded Warrants | not tagged | $0.001 | — | — |
Tranches exactly as the company dimensioned them in its 10-Q filed May 15, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
No warrant figures tagged in this filer’s XBRL facts. That means the company has not reported them in structured form; it does not prove no warrants exist. The exhibits are the ground truth.
Convertible notes
No convertible-note facts tagged in the 10-Q filed May 15, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.
Registrations and offerings
Registered offering capacity on live registrations: $73.6Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted
Last 12 months: 5 executed · 2 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full RNTX workspace